Yann Tan is the founder of Nuevocor. Nuevocor has raised $69M in total funding. Latest round: Series B. Backed by Kurma Partners, Angelini Ventures, EDBI.
Yann Chong Tan is the Founder & CEO of Nuevocor, a Singapore-headquartered biotechnology company that develops gene therapies and mechanobiology-centered treatments for cardiomyopathies. He led the company through a $24 million oversubscribed Series A round in 2021 and a $45 million Series B round in May 2025. Tan is recognized for focusing on rare genetic heart diseases and transitioning Nuevocor from preclinical to IND-stage.
Full founder directory · Investor directory · Company funding database · Fundraising library